Cargando…
Framework conditions facilitating paediatric clinical research
The use of unlicensed and "off-label" medicines in children is widespread. Between 50-80% of the medicines currently administered to children have neither been tested nor authorized for their use in the paediatric population which represents approximately 25% of the whole European populati...
Autores principales: | Knellwolf, Anne-Laure, Bauzon, Stéphane, Alberighi, Ornella Della Casa, Lutsar, Irja, Bácsy, Ernö, Alfarez, Deborah, Panei, Pietro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055809/ https://www.ncbi.nlm.nih.gov/pubmed/21345195 http://dx.doi.org/10.1186/1824-7288-37-12 |
Ejemplares similares
-
Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden
por: Lass, Jana, et al.
Publicado: (2013) -
Global shortage of neonatal and paediatric antibiotic trials: rapid review
por: Thompson, Georgina, et al.
Publicado: (2017) -
Monitoring adherence to guidelines of antibiotic use in pediatric pneumonia: the MAREA study
por: Di Pietro, Pasquale, et al.
Publicado: (2017) -
Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view
por: Folgori, Laura, et al.
Publicado: (2019) -
Italian translation, cultural adaptation and validation of the PedsQL™ 3.0 Diabetes Module questionnaire in children with type 1 diabetes and their parents
por: d’Annunzio, Giuseppe, et al.
Publicado: (2014)